CGEM - Cullinan Oncology GAAP EPS of $3.77 misses by $1.65 August, 10 2022 08:06 AM Cullinan Oncology Inc. Cullinan Oncology press release ( NASDAQ: CGEM ): Q2 GAAP EPS of $3.77 misses by $1.65 . Cash and investments were $656 million For further details see: Cullinan Oncology GAAP EPS of $3.77 misses by $1.65